Femme et Homme
- | Pays :
- Canada
- Poland
- Denmark
- Les 10 autres...
- | Organes : -
- | Spécialités : -
Extrait
This is a randomized, placebo-controlled, double-blind, multicenter phase III/IV study to compare the efficacy and safety of Zemaira® with placebo in subjects with emphysema due to alpha1-proteinase inhibitor deficiency. The effect of Zemaira® on the progression of emphysema will be assessed by the decline of lung density, measured by computed tomography (CT).
Critère d'inclusion
- Alpha1-proteinase Inhibitor Deficiency ,Emphysema